A. Keogh

547 total citations
24 papers, 411 citations indexed

About

A. Keogh is a scholar working on Surgery, Transplantation and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Keogh has authored 24 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 6 papers in Transplantation and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Keogh's work include Transplantation: Methods and Outcomes (11 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). A. Keogh is often cited by papers focused on Transplantation: Methods and Outcomes (11 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). A. Keogh collaborates with scholars based in Australia, United Kingdom and New Zealand. A. Keogh's co-authors include Peter S. Macdonald, Geoffrey W. McCaughan, Timothy H. Mathew, Alex Disney, A. G. R. Sheil, Nicola S. Meagher, Allan R. Glanville, Renhua Na, Andrew E. Grulich and Claire M. Vajdic and has published in prestigious journals such as American Journal of Transplantation, British Journal of Ophthalmology and Acta Paediatrica.

In The Last Decade

A. Keogh

22 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Keogh Australia 10 150 129 107 98 76 24 411
Mary C. Mancini United States 12 249 1.7× 16 0.1× 42 0.4× 108 1.1× 110 1.4× 29 488
Urszula Ołdakowska‐Jedynak Poland 11 97 0.6× 33 0.3× 71 0.7× 23 0.2× 20 0.3× 36 305
R. Ravikumar India 9 390 2.6× 69 0.5× 93 0.9× 8 0.1× 33 0.4× 18 632
E. Solà Spain 13 151 1.0× 118 0.9× 48 0.4× 12 0.1× 277 3.6× 50 477
C. Wullstein Germany 13 496 3.3× 183 1.4× 52 0.5× 80 0.8× 110 1.4× 39 622
Fatimah Al‐Ani Canada 8 61 0.4× 88 0.7× 34 0.3× 61 0.6× 5 0.1× 19 446
Nhu Thao Nguyen Galván United States 12 423 2.8× 45 0.3× 200 1.9× 26 0.3× 174 2.3× 71 670
Tamás Benkö Germany 13 257 1.7× 31 0.2× 82 0.8× 53 0.5× 63 0.8× 35 484
B Huser Switzerland 9 72 0.5× 37 0.3× 43 0.4× 34 0.3× 125 1.6× 22 309
Ahmer Hameed Australia 11 337 2.2× 84 0.7× 19 0.2× 22 0.2× 116 1.5× 38 464

Countries citing papers authored by A. Keogh

Since Specialization
Citations

This map shows the geographic impact of A. Keogh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Keogh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Keogh more than expected).

Fields of papers citing papers by A. Keogh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Keogh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Keogh. The network helps show where A. Keogh may publish in the future.

Co-authorship network of co-authors of A. Keogh

This figure shows the co-authorship network connecting the top 25 collaborators of A. Keogh. A scholar is included among the top collaborators of A. Keogh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Keogh. A. Keogh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robson, D., Andrew Jabbour, Eugene Kotlyar, et al.. (2024). Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in End-Stage Heart Failure Patients Considered for Heart Transplantation. The Journal of Heart and Lung Transplantation. 43(4). S106–S106. 1 indexed citations
2.
Atkin, Catherine, Tanya Pankhurst, David McNulty, et al.. (2022). The impact of changes in coding on mortality reports using the example of sepsis. BMC Medical Informatics and Decision Making. 22(1). 204–204. 3 indexed citations
3.
Anderson, James, John Feenstra, D. Keating, et al.. (2020). Pulmonary Arterial Hypertension with Below Threshold Pulmonary Vascular Resistance. A2048–A2048. 1 indexed citations
4.
Hayward, Chris, et al.. (2015). Potential role of coenzyme Q10 in facilitating recovery from statin‐induced rhabdomyolysis. Internal Medicine Journal. 45(4). 451–453. 4 indexed citations
5.
Kumarasinghe, G., Andrew Parker, Ian Nivison‐Smith, et al.. (2015). Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors. The Journal of Heart and Lung Transplantation. 34(11). 1406–1414. 38 indexed citations
6.
Ruygrok, P., Robert Pettersson, A. Keogh, et al.. (2014). Factors Influencing Waiting Time on the Heart Transplant Waiting List in Australia and New Zealand. The Journal of Heart and Lung Transplantation. 33(4). S262–S262.
7.
Na, Renhua, Andrew E. Grulich, Nicola S. Meagher, et al.. (2013). De novo Cancer-Related Death in Australian Liver and Cardiothoracic Transplant Recipients. American Journal of Transplantation. 13(5). 1296–1304. 60 indexed citations
8.
Kobashigawa, Jon, Daniel Pauly, Bernard Cantin, et al.. (2011). 52 Reduction of Cardiac Allograft Vasculopathy with Everolimus over Mycophenolate Mofetil: Intravascular Ultrasound Results of a Randomized Multicenter Trial. The Journal of Heart and Lung Transplantation. 30(4). S24–S25. 3 indexed citations
9.
10.
Keogh, A., Geoff Strange, Eugene Kotlyar, et al.. (2010). Survival after the initiation of combination therapy in patients with pulmonary arterial hypertension: an Australian collaborative report. Internal Medicine Journal. 41(3). 235–244. 29 indexed citations
11.
Zuckermann, Andreas, José M. Arizón, Shoei‐Shen Wang, et al.. (2008). 161: Impact of De Novo Everolimus-Based Immunosuppression on Wound Healing and Tissue Regeneration in Heart Transplantation. The Journal of Heart and Lung Transplantation. 27(2). S118–S118. 1 indexed citations
12.
Keogh, A., Mark Richardson, Peter Ruygrok, et al.. (2007). 475: Sirolimus vs azathiopine from the time of heart transplantation: 65 month followup for vascular (MACE) and malignant events. The Journal of Heart and Lung Transplantation. 26(2). S231–S232. 3 indexed citations
13.
McCluskey, Peter, et al.. (1998). Ocular complications of heart, lung, and liver transplantation. British Journal of Ophthalmology. 82(4). 423–428. 47 indexed citations
14.
Sheil, A. G. R., et al.. (1997). Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplantation Proceedings. 29(1-2). 825–827. 60 indexed citations
15.
Keogh, A. & A. Kaan. (1992). The Australian and New Zealand Cardiothoracic Organ Transplant Registry: first report 1984ndash;1992. Australian and New Zealand Journal of Medicine. 22(6). 712–717. 11 indexed citations
16.
Esmore, Donald, A. Keogh, P. Spratt, Brett Jones, & Victor P. Chang. (1991). Heart transplantation in females.. PubMed. 10(3). 335–41. 34 indexed citations
17.
Spratt, P, et al.. (1990). Heart/lung transplantation in Australia: early results of the St Vincent's program.. PubMed. 22(5). 2141–2. 2 indexed citations
18.
Spratt, P, et al.. (1989). Comparison of three immunosuppressive protocols in cardiac transplantation.. PubMed. 21(1 Pt 3). 2481–3. 4 indexed citations
19.
Keogh, A., et al.. (1987). Improving Prospects for Surgery in Infants of Birthweight Less than 1 200 Grams. Acta Paediatrica. 76(4). 659–662. 1 indexed citations
20.
Marten, R H, et al.. (1982). Renal Transplantation in Anderson-Fabry Disease. Journal of the Royal Society of Medicine. 75(7). 557–560. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary C. Mancini Breakdown of academic impact, for papers by Urszula Ołdakowska‐Jedynak Breakdown of academic impact, for papers by R. Ravikumar Breakdown of academic impact, for papers by E. Solà Breakdown of academic impact, for papers by C. Wullstein Breakdown of academic impact, for papers by Fatimah Al‐Ani Breakdown of academic impact, for papers by Nhu Thao Nguyen Galván Breakdown of academic impact, for papers by Tamás Benkö Breakdown of academic impact, for papers by B Huser Breakdown of academic impact, for papers by Ahmer Hameed
Rankless by CCL
2026